Filing Details
Elicio Therapeutics, Inc. (NASDAQ:ELTX) filed a Form 8-K with the Securities and Exchange Commission on July 02, 2026, disclosing a material event.
8k filedNASDAQ:ELTX
Elicio Therapeutics, Inc. (ELTX) Reports Material Event to SEC
Filing Details Elicio Therapeutics, Inc. (NASDAQ:ELTX) filed a Form 8-K with the Securities and Exchange Commission on July 02, 2026, disclosing a material event. Market Context…
Market Context
Elicio Therapeutics, Inc.'s stock currently trades at $3.22 with a market capitalization of $144.4M. The Healthcare company's stock moved following the disclosure.
8-K filings report material events that shareholders should know about between regular quarterly or annual reports. These can include leadership changes, material agreements, acquisitions, asset sales, or changes to financial guidance. The specific nature of the event determines its significance for Elicio Therapeutics, Inc.'s stock.
All SEC filings for Elicio Therapeutics, Inc. are publicly available through the SEC's EDGAR database. Investors can set up alerts for new filings to stay current on material developments.
Related Tools: View ELTX Stock Page
Frequently Asked Questions
Where can I read ELTX's SEC filings?
Browse all filings on our ELTX SEC filings page.
What types of SEC filings does Elicio Therapeutics, Inc. file?
Public companies like Elicio Therapeutics, Inc. file annual reports (10-K), quarterly reports (10-Q), material events (8-K), and insider transactions (Form 4) with the SEC.